vanquish

Generic: acetaminophen, aspirin, and caffeine

Labeler: dse healthcare solutions, llc
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name vanquish
Generic Name acetaminophen, aspirin, and caffeine
Labeler dse healthcare solutions, llc
Dosage Form TABLET, COATED
Routes
ORAL
Active Ingredients

acetaminophen 194 mg/1, aspirin 227 mg/1, caffeine 33 mg/1

Manufacturer
DSE Healthcare Solutions, LLC

Identifiers & Regulatory

Product NDC 42364-0011
Product ID 42364-0011_07ad62bb-147a-4760-9723-81334658bb9c
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Marketing Start 2018-07-15
Marketing End 2026-08-31

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc] central nervous system stimulant [epc] methylxanthine [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs] xanthines [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe] central nervous system stimulation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 423640011
Hyphenated Format 42364-0011

Supplemental Identifiers

RxCUI
243694 1101754
UNII
362O9ITL9D R16CO5Y76E 3G6A5W338E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832 N0000175739 N0000175729 N0000175790 M0023046

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vanquish (source: ndc)
Generic Name acetaminophen, aspirin, and caffeine (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 194 mg/1
  • 227 mg/1
  • 33 mg/1
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (42364-0011-1) / 100 TABLET, COATED in 1 BOTTLE
  • 1 BOTTLE in 1 CARTON (42364-0011-2) / 120 TABLET, COATED in 1 BOTTLE
source: ndc

Packages (2)

42364-0011-1 1 BOTTLE in 1 CARTON (42364-0011-1) / 100 TABLET, COATED in 1 BOTTLE 42364-0011-2 1 BOTTLE in 1 CARTON (42364-0011-2) / 120 TABLET, COATED in 1 BOTTLE

Ingredients (3)

acetaminophen (194 mg/1) aspirin (227 mg/1) caffeine (33 mg/1)

Linked Drug Pages (1)

vanquish ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "07ad62bb-147a-4760-9723-81334658bb9c", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["243694", "1101754"], "spl_set_id": ["f879e8c7-1983-4a85-b87d-38f5068351fc"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["DSE Healthcare Solutions, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (42364-0011-1)  / 100 TABLET, COATED in 1 BOTTLE", "package_ndc": "42364-0011-1", "marketing_end_date": "20260831", "marketing_start_date": "20180715"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (42364-0011-2)  / 120 TABLET, COATED in 1 BOTTLE", "package_ndc": "42364-0011-2", "marketing_end_date": "20260831", "marketing_start_date": "20180715"}], "brand_name": "vanquish", "product_id": "42364-0011_07ad62bb-147a-4760-9723-81334658bb9c", "dosage_form": "TABLET, COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "42364-0011", "generic_name": "acetaminophen, aspirin, and caffeine", "labeler_name": "DSE Healthcare Solutions, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "vanquish", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "194 mg/1"}, {"name": "ASPIRIN", "strength": "227 mg/1"}, {"name": "CAFFEINE", "strength": "33 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_end_date": "20260831", "marketing_start_date": "20180715"}